Summary
Peripheral blood leukocytes were collected from 5 Thoroughbred horses and examined for the presence of EHV2 in sub-populations of mono-nuclear cells. Peripheral blood mononuclear cells were separated on Percoll gradients and then enriched for plastic adherent cells (predominantly mono-cytes), surface immunoglobulin positive (sIg+) B lymphocytes and T lymphocytes, using panning techniques. The purity of each cell population was assessed by fluorescence activated cell scanning. In an infectious centre assay, each cell population was inoculated onto equine foetal kidney monolayer cell cultures which are fully permissive for the replication of EHV2. Only enrichment for sIg+ B lymphocytes resulted in a marked increase in the number of infectious centres, indicating that EHV2 is present in B lymphocytes. Freeze-thawing of sIg+ B lymphocytes, prior to inoculation onto EFK monolayer cell cultures, resulted in the complete abrogation of infectious centre formation, confirming that EHV2 is latent in B lymphocytes i.e., infectious free virus was not present in the cells. The number of EHV2 infected B lymphocytes varied considerably between horses from 4 to 780 per 106 cells. Evidence was also obtained that direct cell to cell contact between the epithelial cells and sIg+ B lymphocytes was necessary for the production of infectious centres. The data indicate that EHV2, like other members of theGammaherpesvirinae, is latent within B lymphocytes.
Article PDF
Similar content being viewed by others
References
Agius CT, Studdert MJ (1994) Equine herpesviruses 2 and 5; comparisons with other members of the subfamilyGammaherpesvirinae. Adv Virus Res 44: 357–379
Belak S, Palfi V, Tuboly S, Bartha L (1980) Passive immunization of foals to prevent respiratory disease caused by equine herpesvirus type 2. Zentralbl Veterinarmed [B] 27: 826–830
Blakeslee JR Jr, Olsen RG, McAllister ES, Fassbender J, Dennis R (1975) Evidence of respiratory tract infection induced by equine herpesvirus, type 2, in the horse. Can J Microbiol 21: 1940–1946
Blanchard-Channell M, Moore PF, Stott JL (1994) Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5. Immunology 82: 548–554
Hsu DH, de Waal-Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830–832
Jolly PD, Tu ZF, Robinson AJ (1986) Viruses associated with respiratory disease of horses in New Zealand: an update. N Z Vet J 34: 46–50
Kemeny L, Pearson JE (1970) Isolation of herpesvirus from equine leukocytes: comparison with equine rhinopneumonitis virus. Can J Comp Med 34: 59–65
Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ (1992) Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176: 169–176
Klein G (1989) Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58: 5–8
Kramp WJ, Medveczky P, Mulder C, Hinze HC, Sullivan JL (1985) Herpesvirus sylvilagus infects both B and T lymphocytes in vivo. J Virol 56: 60–65
Mage MG, McHugh LL, Rothstein TL (1977) Mouse lymphocytes with and without surface immunoglobulin; preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods 15: 47–56
Mason DW, Penhale WJ, Sedgwick JD (1987) Preparation of lymphocytic subpopulations. In: Vlaus GGB (ed) Lymphocytes. A practical approach, IRL Press, Oxford, Washington, pp 35–54
Miller G (1990) Epstein-Barrvirus: biology, pathogenesis, and medical aspects. In: Fields B (ed) Virology. Raven Press, New York, pp 1921–1957
Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI [published erratum appears in Science 250: 494 (1990)]. Science 248: 1230–1234
Moss DJ, Misko IS, Sculley TB, Appoloni A, Khanna R, Burrows SR (1992) Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigens as a target for EBV-specific T cell lysis. Springer Semin Immunopathol 13: 147–156
Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176: 157–168
Palfi V, Belak S, Molnar T (1978) Isolation of equine herpesvirus type 2 from foals, showing respiratory symptoms. Zentralbl Veterinarmed [B] 25: 165–167
Reubel GH, Crabb BS, Studdert MJ (1995) Diagnosis of equine gammaherpesvirus 2 and 5 infections by polymerase chain reaction. Arch Virol 140: 1049–1060
Rode HJ, Janssen W, Rosen-Wolff A, Bugert JJ, Thein P, Becker Y, Darai G (1993) The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL 10)-like gene. Virus Genes 7: 111–116
Roeder PL, Scott GR (1975) The prevalence of equid herpes virus 2 infections. Vet Rec 96: 404–405
Roizman B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ (1992) The family Herpesviridae: an update. Arch Virol 123: 425–449
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York
Studdert MJ (1971) Equine herpesviruses. 4. Concurrent infection in horses with strangles and conjunctivitis. Aust Vet J 47: 434–436
Sugiura T, Fukuzawa Y, Kamada M, Ando Y, Hirasawa K (1983) Isolation of equine herpesvirus type 2 from foals with pneumonitis. Bull Equine Res Inst 20: 148–153
Sunil-Chandra NP, Efstathiou S, Nash AA (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73: 3275–3279
Telford EA, Watson MS, Aird HC, Perry J, Davison AJ (1995) The DNA sequence of equine herpesvirus 2. J Mol Biol 249: 520–528
Telford EAR, Studdert MJ, Agius CT, Watson MS, Aird HC, Davison AJ (1993) Equine herpesviruses 2 and 5 are γ-herpesviruses. Virology 195: 492–499
Turner AJ, Studdert MJ, Peterson JE (1970) Equine herpesviruses 2. Persistence of equine herpesviruses in experimentally infected horses and in the experimental induction of abortion. Aust Vet J 46: 90–98
Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88: 1172–1176
Welch HM, Bridges CG, Lyon AM, Griffiths L, Edington N (1992) Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73: 261–268
Wilks CR, Studdert MJ (1974) Equine herpesviruses. 5. Epizootiology of slowly cytopathic viruses in foals. Aust Vet J 50: 438–442
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drummer, H.E., Reubel, G.H. & Studdert, M.J. Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes. Archives of Virology 141, 495–504 (1996). https://doi.org/10.1007/BF01718313
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01718313